SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-19-035768
Filing Date
2019-09-27
Accepted
2019-09-27 16:40:39
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 odt-s3.htm S-3 212182
2 EX-5.1 odt-ex51_6.htm EX-5.1 21000
3 EX-23.1 odt-ex231_7.htm EX-23.1 3081
4 GRAPHIC gpkybgettvkg000001.jpg GRAPHIC 89690
5 GRAPHIC g3sp0tibmxtc000002.jpg GRAPHIC 28085
6 GRAPHIC g3sp0tibmxtc000001.jpg GRAPHIC 4471
  Complete submission text file 0001564590-19-035768.txt   406170
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-233990 | Film No.: 191122558
SIC: 2834 Pharmaceutical Preparations